Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists

Feb. 22, 2022

New curcumin derivatives show activity against non-small lung cancer

Feb. 22, 2022

CC40.8 antibody confers protection against SARS-CoV-2 infection

Feb. 22, 2022

LCDR regulates lysosomal function through stabilization of LAPTM5 and promotes cancer cell survival

Feb. 22, 2022

"Twin study" of sorts brings insight into arthritis microbiome

Feb. 21, 2022

GR-3027 reverses neuroinflammation in rat model of hyperammonemia

Feb. 21, 2022

SIGMAR1 targeting ameliorates preclinical Wolfram syndrome symptoms

Feb. 21, 2022

Moderna announces new mRNA vaccine candidates for HSV, VZV and cancer

Feb. 21, 2022

CD70 identified as promising therapeutic target in advanced RCC

Feb. 21, 2022

DNA methylation mediated by METTL3-METTL14 complex is largely restricted by structured RNA elements

Feb. 21, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...